AGM Predictions, page-8

I still follow the company and have a few questions I would love to see answered.

The price is currently tempting, given cash backing.

I suspect it's going to be like getting blood out of a stone to get straight answers out of these guys.

I reckon questions will need to be very carefully constructed to get any meaningful information (hopefully) from management.

I hope someone can take detailed notes and provide a comprehensive report here.

My questions are as follows,

1. Why does management choose not to be transparent with the market (including shareholders) by not giving a breakdown of sales revenue and interest revenue in the quarterly reports released to the ASX?

2. How are shareholders meant to judge the success of the business if they don't know how much revenue is coming from sales? We can't rely on delivery numbers as there is no transparency about trials etc.

3. On 18/12/17 GSW advised the ASX that CBA and GSW "will jointly address and market the new product from February 2018 onwards"

How is the marketing progressing?

4. On 11/12/17 GSW raised $75m in part "to accelerate its conversion of strong demand opportunities in its global client pipeline".

How is this progressing? Are management expectations being met?

5. On 1/12/17 GSW announced a global agreement with with Amazon.

Is this proceeding within expectations?

6. On 12/9/17 GSW announced the N A Williams agreement, citing an integration process of 15/19 months.

Is this integration still on track?